MDT

100.81

+0.69%↑

A

139.19

+2.17%↑

VEEV

224.79

+2.19%↑

HQY

85.18

+0.72%↑

NEOG

9.99

+5.83%↑

MDT

100.81

+0.69%↑

A

139.19

+2.17%↑

VEEV

224.79

+2.19%↑

HQY

85.18

+0.72%↑

NEOG

9.99

+5.83%↑

MDT

100.81

+0.69%↑

A

139.19

+2.17%↑

VEEV

224.79

+2.19%↑

HQY

85.18

+0.72%↑

NEOG

9.99

+5.83%↑

MDT

100.81

+0.69%↑

A

139.19

+2.17%↑

VEEV

224.79

+2.19%↑

HQY

85.18

+0.72%↑

NEOG

9.99

+5.83%↑

MDT

100.81

+0.69%↑

A

139.19

+2.17%↑

VEEV

224.79

+2.19%↑

HQY

85.18

+0.72%↑

NEOG

9.99

+5.83%↑

Search

Zevra Therapeutics Inc

Open

9.12 1.11

Overview

Share price change

24h

Current

Min

8.69

Max

9.04

Key metrics

By Trading Economics

Income

-75M

-544K

Sales

182K

26M

P/E

Sector Avg

19

89.037

Profit margin

-2.087

Employees

59

EBITDA

73M

1.5M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+166.08% upside

Dividends

By Dow Jones

Next Earnings

10 mar 2026

Market Stats

By TradingEconomics

Market Cap

-70M

503M

Previous open

8.01

Previous close

9.12

Zevra Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

27 lut 2025, 15:29 UTC

Acquisitions, Mergers, Takeovers

Zevra Therapeutics to Sell Priority-Review Voucher for $150 Million

Peer Comparison

Price change

Zevra Therapeutics Inc Forecast

Price Target

By TipRanks

166.08% upside

12 Months Forecast

Average 24 USD  166.08%

High 26 USD

Low 21 USD

Based on 6 Wall Street analysts offering 12 month price targets forZevra Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat